143 related articles for article (PubMed ID: 32816219)
1. Use of Azithromycin in COVID-19: A Cautionary Tale.
Kow CS; Hasan SS
Clin Drug Investig; 2020 Oct; 40(10):989-990. PubMed ID: 32816219
[No Abstract] [Full Text] [Related]
2. Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.
Parra-Lara LG; Martínez-Arboleda JJ; Rosso F
J Glob Antimicrob Resist; 2020 Sep; 22():680-684. PubMed ID: 32622008
[TBL] [Abstract][Full Text] [Related]
3. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
Schluger NW
Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin for severe COVID-19.
Oldenburg CE; Doan T
Lancet; 2020 Oct; 396(10256):936-937. PubMed ID: 32896293
[No Abstract] [Full Text] [Related]
5. Hydroxychloroquine and azithromycin as a treatment of COVID-19.
Fanin A; Calegari J; Beverina A; Tiraboschi S;
Intern Emerg Med; 2020 Aug; 15(5):841-843. PubMed ID: 32474851
[No Abstract] [Full Text] [Related]
6. Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
Popescu CP; Fischer PR
Travel Med Infect Dis; 2020; 35():101764. PubMed ID: 32485391
[No Abstract] [Full Text] [Related]
7. Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.
Pothen L; Yildiz H; De Greef J; Penaloza A; Beauloye C; Belkhir L; Yombi JC
Travel Med Infect Dis; 2020; 36():101788. PubMed ID: 32540396
[No Abstract] [Full Text] [Related]
8. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
Lebeaux D; Revest M
Travel Med Infect Dis; 2020; 36():101819. PubMed ID: 32629139
[No Abstract] [Full Text] [Related]
9. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
Frigerio M
Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
[No Abstract] [Full Text] [Related]
10. Pharmacist's perspective on HCQ treatment of COVID-19.
Wang YL; Wang SH; Yang AY
Kaohsiung J Med Sci; 2020 Aug; 36(8):660. PubMed ID: 32533592
[No Abstract] [Full Text] [Related]
11. Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19".
Atkinson JG
Int J Infect Dis; 2020 Oct; 99():37. PubMed ID: 32738492
[No Abstract] [Full Text] [Related]
12. [Not Available].
Farfán-López M; Espinoza-Culupú A
Rev Peru Med Exp Salud Publica; 2020; 37(2):383-384. PubMed ID: 32876237
[No Abstract] [Full Text] [Related]
13. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment.
Roden DM; Harrington RA; Poppas A; Russo AM
Heart Rhythm; 2020 Jul; 17(7):e231-e232. PubMed ID: 32302703
[No Abstract] [Full Text] [Related]
14. Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.
Mazzitelli M; Davoli C; Scaglione V; Fusco P; La Gamba V; Matera G; Trecarichi EM; Torti C
Travel Med Infect Dis; 2020; 37():101826. PubMed ID: 32739472
[No Abstract] [Full Text] [Related]
15. Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
Bonow RO; Hernandez AF; Turakhia M
JAMA Cardiol; 2020 Sep; 5(9):986-987. PubMed ID: 32936259
[No Abstract] [Full Text] [Related]
16. Flexibilization of Science, Cognitive Biases, and the COVID-19 Pandemic.
Oliveira J E Silva L; Vidor MV; Zarpellon de Araújo V; Bellolio F
Mayo Clin Proc; 2020 Sep; 95(9):1842-1844. PubMed ID: 32861327
[No Abstract] [Full Text] [Related]
17. Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.
Rosendaal FR
Int J Antimicrob Agents; 2020 Jul; 56(1):106063. PubMed ID: 32674928
[No Abstract] [Full Text] [Related]
18. Cancer Progression Is Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis.
McDonald R
Oncology (Williston Park); 2020 Jul; 34(7):249. PubMed ID: 32674206
[TBL] [Abstract][Full Text] [Related]
19. Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
Varisco TJ; Johnson ML; Thornton D
Int J Infect Dis; 2020 Oct; 99():373. PubMed ID: 32771630
[No Abstract] [Full Text] [Related]
20. Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
Bonny A; Talle MA; Ngantcha M; Tayebjee MH
Travel Med Infect Dis; 2020; 37():101861. PubMed ID: 32889105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
